Q. Hong

1.0k total citations
8 papers, 239 citations indexed

About

Q. Hong is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Q. Hong has authored 8 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Q. Hong's work include Cancer Immunotherapy and Biomarkers (5 papers), Bladder and Urothelial Cancer Treatments (3 papers) and HER2/EGFR in Cancer Research (2 papers). Q. Hong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Bladder and Urothelial Cancer Treatments (3 papers) and HER2/EGFR in Cancer Research (2 papers). Q. Hong collaborates with scholars based in United States, France and Spain. Q. Hong's co-authors include Trishna Goswami, Sara M. Tolaney, Aditya Bardia, Joyce O’Shaughnessy, Kevin Kalinsky, IA Mayer, R Moroose, David M. Goldenberg, Jennifer R. Diamond and Dejan Juric and has published in prestigious journals such as Annals of Oncology and Leukemia Research Reports.

In The Last Decade

Q. Hong

7 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Q. Hong United States 6 197 96 52 46 37 8 239
Giuliano Santos Borges Brazil 7 138 0.7× 97 1.0× 36 0.7× 22 0.5× 33 0.9× 16 183
Stefano Panni Italy 7 141 0.7× 61 0.6× 19 0.4× 15 0.3× 32 0.9× 23 182
Míriam Arumí Spain 5 113 0.6× 80 0.8× 37 0.7× 33 0.7× 18 0.5× 13 172
Miao Huang China 9 184 0.9× 159 1.7× 33 0.6× 61 1.3× 23 0.6× 17 298
Laura Ginocchi Italy 8 119 0.6× 67 0.7× 27 0.5× 47 1.0× 44 1.2× 17 183
Haiyi Deng China 10 172 0.9× 151 1.6× 22 0.4× 34 0.7× 26 0.7× 33 246
A. Stopeck United States 9 242 1.2× 80 0.8× 56 1.1× 68 1.5× 15 0.4× 20 295
Takehiro Tozuka Japan 10 198 1.0× 156 1.6× 17 0.3× 28 0.6× 18 0.5× 33 249
Mariela A. Blum Murphy United States 9 158 0.8× 134 1.4× 52 1.0× 25 0.5× 98 2.6× 30 258
Carlos Dzik Brazil 9 44 0.2× 94 1.0× 29 0.6× 49 1.1× 19 0.5× 26 151

Countries citing papers authored by Q. Hong

Since Specialization
Citations

This map shows the geographic impact of Q. Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Q. Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Q. Hong more than expected).

Fields of papers citing papers by Q. Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Q. Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Q. Hong. The network helps show where Q. Hong may publish in the future.

Co-authorship network of co-authors of Q. Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Q. Hong. A scholar is included among the top collaborators of Q. Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Q. Hong. Q. Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Hong, Q., et al.. (2022). Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes. Leukemia Research Reports. 18. 100343–100343.
2.
Kalinsky, Kevin, Jennifer R. Diamond, Linda T. Vahdat, et al.. (2020). Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trial. Annals of Oncology. 31(12). 1709–1718. 111 indexed citations
3.
4.
Loriot, Yohann, Arjun Vasant Balar, Daniel P. Petrylak, et al.. (2020). LBA24 TROPHY-U-01 cohort 1 final results: A phase II study of sacituzumab govitecan (SG) in metastatic urothelial cancer (mUC) that has progressed after platinum (PLT) and checkpoint inhibitors (CPI). Annals of Oncology. 31. S1156–S1156. 19 indexed citations
5.
6.
7.
Choueiri, Toni K., Mayer Fishman, Bernard Escudier, et al.. (2014). Immunomodulatory Activity of Nivolumab in Previously Treated and Untreated Metastatic Renal Cell Carcinoma (Mrcc): Biomarker-Based Results from a Randomized Clinical Trial. Annals of Oncology. 25. iv362–iv362. 18 indexed citations
8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuliano Santos Borges Breakdown of academic impact, for papers by Stefano Panni Breakdown of academic impact, for papers by Míriam Arumí Breakdown of academic impact, for papers by Miao Huang Breakdown of academic impact, for papers by Laura Ginocchi Breakdown of academic impact, for papers by Haiyi Deng Breakdown of academic impact, for papers by A. Stopeck Breakdown of academic impact, for papers by Takehiro Tozuka Breakdown of academic impact, for papers by Mariela A. Blum Murphy Breakdown of academic impact, for papers by Carlos Dzik
Rankless by CCL
2026